Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Ginkgo Biloba For The Prevention Of Chemotherapy-Related Cognitive Dysfunction

NCT00046891 is registered in ClinicalTrials.gov with Alliance for Clinical Trials in Oncology as lead sponsor.

NCT NCT00046891
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00046891 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Ginkgo Biloba For The Prevention Of Chemotherapy-Related Cognitive Dysfunction
Lead sponsor
Alliance for Clinical Trials in Oncology
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2002
Completion date
April 30, 2015
Enrollment
226 (actual)
Sites
175

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, neurotoxicity